Outcomes of transition from selexipag to parenteral prostacyclin analogues in patients with pulmonary arterial hypertension.
Ebrahim AlEissa, Lisa Kolkman, Ali Kapasi, Defen Peng, Steeve Provencher, Nathan Brunner, John Swiston
原始摘要（英文原文）· Original abstract
Transitioning from selexipag to parenteral prostacyclin analogues yielded haemodynamic improvement. Outcomes are poor among those within this population who do not achieve a low-risk status after the transition. https://bit.ly/4sMY3aF.